LL‐37 and Its Truncated Fragments Modulate Amyloid‐β Dynamics, Aggregation and Toxicity Through Hetero‐Oligomer and Cluster Formation
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202516241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Xue Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Chemistry, Paul Scherrer Institute, Forschungsstrasse 111, Villigen, PSI, 5232, Switzerland. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Cathelicidins, Antimicrobial Cationic Peptides, Peptide Fragments. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
LL‐37 and its variants with amphiphilic structure can modulate amyloid‐β (Aβ) fibril formation, but the detailed mechanism behind it is still unclear. By using four different peptides (LL‐37, LL‐37 9–32 , LL‐37 18–29 , LL‐37 19–28 ), we found these peptides affect Aβ40 aggregation differently. Nanoscale analysis showed that all LL‐37 peptides form hetero‐oligomers and nanoclusters with Aβ40, but LL‐37 and LL‐37 19–28 , which exhibit the strongest inhibition of Aβ fibrillation, form more hetero‐oligomers and smaller nanoclusters. This suggests that hetero‐oligomers and small nanoclusters may represent an off‐pathway, preventing the formation of productive aggregates. At the microscale, all LL‐37 peptides were found to promote Aβ cluster formation, but LL‐37 and LL‐37 19–28 can form larger clusters with Aβ rapidly, emphasizing that smaller nanoclusters can assemble to macroscale clusters easier, inducing more toxic aggregates. Both nanoscopic and microscopic mechanisms revealed inhibition of Aβ fibrillation by all LL‐37 peptides, impacting Aβ primary and secondary nucleation, while only LL‐37 and LL‐37 19–28 affected Aβ elongation. Our findings highlight the role of LL‐37 and its synthetic fragments in Aβ40 aggregation across different scales, particularly focusing on cluster formation at the nanoscale and microscale to fill the knowledge gap between oligomerization and fibrillation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Chemistry, Paul Scherrer Institute, Forschungsstrasse 111, Villigen, PSI, 5232, Switzerland.
- Department of Biochemistry and Biophysics, Stockholm University, Stockholm, 106 91, Sweden.
- Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, 106 91, Sweden.
- Department of Medicine Huddinge, Karolinska Institutet, Huddinge, 141 52, Sweden.
- Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, University of Nebraska, 985900 Nebraska Medical Center, Omaha, NE, 68198-5900, USA.
ORCID-Profile: Jinghui Luo
Förderung
- NIAID NIH HHS
Zitieren
APA
Wang, X., Österlund, N., Pereira Curia, G., Mörman, C., Sternke-Hoffmann, R., L Ilag, L., Gräslund, A., Wang, G., & Luo, J. (2025). LL‐37 and Its Truncated Fragments Modulate Amyloid‐β Dynamics, Aggregation and Toxicity Through Hetero‐Oligomer and Cluster Formation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202516241
Vancouver
Wang X, Österlund N, Pereira Curia G, Mörman C, Sternke-Hoffmann R, L Ilag L, et al. LL‐37 and Its Truncated Fragments Modulate Amyloid‐β Dynamics, Aggregation and Toxicity Through Hetero‐Oligomer and Cluster Formation. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202516241
BibTeX
@article{Wang2025,
author = {Wang, Xue and Österlund, Nicklas and Pereira Curia, Guadalupe and Mörman, Cecilia and Sternke-Hoffmann, Rebecca and L Ilag, Leopold and Gräslund, Astrid and Wang, Guangshun and Luo, Jinghui},
title = {LL‐37 and Its Truncated Fragments Modulate Amyloid‐β Dynamics, Aggregation and Toxicity Through Hetero‐Oligomer and Cluster Formation},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202516241}
}
EUVIMED